It's always a joyful moment when a new baby is born. Everyone in the family wants to come meet the new addition. A few days later, this precious little baby is struggling to breathe and needs to be in ...

RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...

MONTANA - As the colder months approach, the Montana Department of Public Health and Human Services (DPHHS) is urging ...

Should you take vitamin C or zinc when you are sick with a common cold or influenza? Immunologist Zachary Rubin explains ...

Most of us grew up with home remedies being passed down by wise relatives, but a lot of the time, those "tips and tricks" are just old wives' tales. That said, there are a slew of home remedies that ...

Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and payors Lasix ONYU is the 17 th Captisol-enabled™ approved product JUPITER, Fla.

Posters will be available to view on the conference platform during the conference and on the Company’s website here after presentations. Further information about IDWeek™ 2025 can be found here.

Sept 29 (Reuters) - Enanta Pharmaceuticals (ENTA.O), opens new tab said its experimental respiratory syncytial virus treatment significantly quickened recovery in a mid-stage study of adults at high ...

Enata Pharmaceuticals said it didn't meet its primary endpoint in a Phase 2b study of zelicapavir, its proposed treatment for Respiratory Syncytial Virus, or RSV, in high-risk adults. The Watertown, ...

(Reuters) -Enanta Pharmaceuticals said on Monday its treatment for respiratory syncytial virus failed to shorten the time taken to reduce the severity of some symptoms, missing the primary goal of a ...